-
4 weeks ago | 
dermatologytimes.com | Mercedes E. Gonzalez |Mercedes González |Heidi Anne Duerr
Following the 37th Annual Society for Pediatric Dermatology (SPD) Pre-Meeting in Orlando, Florida, Dermatology Times spoke with Mercedes E. Gonzalez, MD, co-chair of the meeting, to reflect on the key takeaways from the conference. This year’s pre-meeting covered a range of critical topics, from emerging treatments to evolving best practices in pediatric dermatology.
-
1 month ago | 
psychiatrictimes.com | Joseph F. Goldberg |Heidi Anne Duerr
On March 21, 2025, 6 psychiatric organizations published a joint statement to reaffirm the safety and efficacy of psychotropic medications when used appropriately. The statement was aimed to bring clarity following an executive order questioning the safety of various psychotropic medications.
-
1 month ago | 
psychiatrictimes.com | John J. Miller |Heidi Anne Duerr
Following the release of a joint statement1 from leading psychiatric organizations voicing concern over Executive Order 14212, Psychiatric Times spoke with its Editor-in-Chief, John J. Miller, MD, to discuss the implications of this federal directive and the response from the psychiatric community.
-
1 month ago | 
psychiatrictimes.com | Heidi Anne Duerr
In a joint statement released today, leading psychiatric organizations addressed the February 14, 2025, Executive Order 14212, which called for an assessment of the risks associated with psychotropic medications, including selective serotonin reuptake inhibitors (SSRIs), antipsychotics, mood stabilizers, and stimulants.1,2 The statement, signed by the American Psychiatric Association (APA), the American Academy of Child & Adolescent Psychiatry (AACAP), the American College of...
-
1 month ago | 
dermatologytimes.com | Robert Bissonnette |Heidi Anne Duerr
NewsArticleMarch 12, 2025Author(s):,Bissonnette shared highlights and insights on the icotrokinra data presented at the AAD Annual Meeting.
-
1 month ago | 
dermatologytimes.com | Brian Kim |Heidi Anne Duerr
NewsArticleMarch 10, 2025Author(s):,Brian S. Kim, MD, FAAD, shares itch research updates at the AAD Annual Meeting. “The flavor of what's going on in AD has really shifted so much and immunodermatology has really come to the forefront,” Brian S. Kim, MD, FAAD, told Dermatology Times at the 2025 American Academy of Dermatology Annual Meeting in Orlanda, Florida.
-
1 month ago | 
dermatologytimes.com | Denise Metry |Heidi Anne Duerr
“When you have a hemangioma—a infantile hemangioma that's larger, more what we call segmental, not round, patterned, often syndromic—what is the role of laser in those children? And especially the timing—should we be thinking about potentially lasering earlier than we traditionally have?” Denise W.
-
1 month ago | 
dermatologytimes.com | Kristen Kelly |Heidi Anne Duerr
Kristen Marie Kelly, MD, FAAD, highlighted promising advancements in the treatment of vascular malformations, particularly port-wine birthmarks at the American Academy of Dermatology (AAD) Annual Meeting.1 Although lasers have significantly improved patient outcomes, she said, some lesions remain resistant, and recurrence continues to be a challenge. However, Kelly said new research offers hope for more effective therapies.
-
1 month ago | 
dermatologytimes.com | Roy G. Geronemus |Heidi Anne Duerr
Author(s):,At the AAD Annual Meeting, Roy G. Geronemus, MD, emphasized the importance of early interventions for port wine stains. Early intervention dramatically improves treatment outcomes, Roy G.
-
1 month ago | 
dermatologytimes.com | JiaDe Yu |Heidi Anne Duerr
JiaDe 'Jeff' Yu, MD, FAAD, a dermatologist at Massachusetts General Hospital in Boston, shared highlights from his presentations on the importance of recognizing and effectively managing allergic contact dermatitis at the 2025 American Academy of Dermatology (AAD) Annual Meeting.1 Yu emphasized that allergic contact dermatitis remains largely underrecognized and undertested, leading to inadequate treatment for affected children and adults.
